Analyst IMS Investment Management Services Ltd.
Position in NVO — Novo Nordisk A S
CIK 1634208
Tel-aviv, L3
Position in NVO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$19,692,313
+$4,563,441 QoQ
Shares Held
410,770
-0.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#99
of 1,348 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Analyst IMS Investment Management Services Ltd. holds $26,750,918 across 7 Drug Manufacturers - General names. NVO ranks #1 (73.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
410,770 | $19,692,313 | |
| 2 | LLY |
ELI LILLY & Co
|
2,047 | $2,455,233 | |
| 3 | JNJ |
Johnson & Johnson
|
8,024 | $2,037,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,995 | $1,155,857 | |
| 5 | ABBV |
AbbVie Inc.
|
3,869 | $973,595 | |
| 6 | SNY |
Sanofi
|
5,208 | $222,173 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,693 | $213,893 |
All Filings in NVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,692,313 | 410,770 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $15,128,872 | 411,670 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $308,841 | 6,070 | Shares | Defined | 2026-01-20 | |
| 2024-09-30 | $476,755 | 4,004 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $571,530 | 4,004 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $514,113 | 4,004 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||